Serono Symposia International Foundation adheres to guidelines of the European Accreditation Council for Continuing Medical Education (EACCME) and all other professional organizations, as applicable, which state that programs awarding continuing education credits must be balanced, independent, objective, and scientifically rigorous. Investigative and other uses for pharmaceutical agents, medical devices, and other products (other than those uses indicated in approved product labeling/package insert for the product) may be presented in the program (which may reflect clinical experience, the professional literature or other clinical sources known to the presenter). We ask all presenters to provide participants with information about relationships with pharmaceutical or medical equipment companies that may have relevance to their lectures. This policy is not intended to exclude faculty who have relationships with such companies; it is only intended to inform participants of any potential conflicts so participants may form their own judgments, based on full disclosure of the facts. Further, all opinions and recommendations presented during the program and all program-related materials neither imply an endorsement, nor a recommendation, on the part of Serono Symposia International Foundation. All presentations solely represent the independent views of the presenters/authors.
The following faculty indicated no significant commercial relationships and/or discussions of investigational or non- EMEA/FDA approved (off-label) uses of drugs:
Frank J. Broekmans
Didier Dewailly
Thomas Ebner
Jean Noël Hugues
Gianpiero D. Palermo
Jacqueline Selva
The following faculty provided information regarding significant commercial relationships and/or discussions of investigational or non- EMEA/FDA approved (off-label) uses of drugs:
Andrea Borini: Declared receipts of honoraria or consultation fees from Ferring and to have been Member of Merck Serono advisory board.
Ernest Bosch: Declared receipts of honoraria or consultation fees from Merck-Serono and participation in a Merck-Serono sponsored speaker’s bureau.
Dominique De Ziegler: Declared to have been member of Ferring, IBSA and Merck Serono advisory boards, board of directors or other similar group and to be stakeholder in Ultract LLC.
Bart C.J.M. Fauser: Declared receipts of grants and contracts from Organon and Merck Serono.
François Olivennes: Declared receipts of honoraria or consultation fees from Merck Serono and Organon.
Jerome F. Strauss III: Declared receipts of grants and contracts from NIH, March of Dimes and honoraria or consultation fees from EMD Serono. Declared to have been member of Femme Pharma, Endoceutics advisory board, board of directors or other similar group and to be stakeholder in Targeted Genetics, Femme Pharma.
Dagan Wells: Declared receipts of honoraria or consultation fees from EMD Serono and to be stakeholder in Reprogenetics.
